StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

(S)-1-[N-[1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-prolinmaleat

Enalapril Maleate

HCID 5388961
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
76095-16-4
Standard-SMILES
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\C(=O)O
InChIKey
OYFJQPXVCSSHAI-QFPUQLAESA-N
Summenformel
C24H32N2O9
Durchschnittliche Molmasse
492,5 g/mol
Monoisotopische Masse
492,2107806

Überblick

Enalapril maleate is the maleic acid salt of enalapril. It contains one molecule of maleic acid for each molecule of enalapril. Following oral administration, the ethyl ester group of enalapril is hydrolysed to afford the corresponding carboxylic acid, enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor. Enalapril is thus a prodrug for enalaprilat (which, unlike enalapril, is not absorbed by mouth), and its maleate is used in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, an antihypertensive agent and a prodrug. It contains an enalapril.

Namen und Bezeichner

Bevorzugter Name
Enalapril Maleate
IUPAC
(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
Lokaler Name
(S)-1-[N-[1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-prolinmaleat
Englischer Name
Enalapril maleate
Summenformel
C24H32N2O9
Molmasse
492.52

Namen und Synonyme

Enalapril maleate76095-16-4GliotenRenitecNaprileneXanefVasotecHipoartelInnovaceAmpraceEnacardEnapren
Weitere Namen anzeigen
OlivinEnalapril Maleate SaltRenitekRenivace(S)-1-((S)-2-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID MALEATEBQLEnvasNuril
RenitenPresEdnytEpanedEpaned KitMK-421CARDIOVETNSC-758143

Datenbank-Bezeichner

CAS
76095-16-4、76420-75-2
PubChem CID
5388961
DTXSID
DTXSID30896796
ChEMBL
CHEMBL1200659
ChEBI
CHEBI:4785
UNII
9O25354EPJ

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
171 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
10
Frei drehbare Bindungen
12
Schwere Atome
35
Formalladung
0
Komplexität
637

Experimentelle und physikochemische Eigenschaften

Human Drugs · 4 Einträge

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors; ACE Inhibitors; ACEIs

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Collision Cross Section186.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
143 · 143-144,5°C
Siedepunkt
0 °C · 0°C
Dichte
1.27 g/cm³ · 1.27 g/cm³ (liquid)
Flammpunkt
0 °C · 0°C
storage temp.
2 · 2-8°C
Löslichkeit
50 mg/mL, · methanol: ≥50 mg/mL, clear, colorless to yellow
Aggregatzustand
powder
pka
1 · pKa1 3.0; pKa2 (25°) 5.4
Farbe
white to off-white

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 1% (2 of 202) of reports.

Danger

H302 (19.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P263, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P305+P354+P338, P317, P318, P319, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 202 reports by companies from 27 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationEnalapril maleate: Non hazardous
Hazard Classes and CategoriesAcute Tox. 4 (19.3%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Enalapril maleate

vLess-DILI-concern

7

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

wgk
2
ridadr
3077
hs_code
29339900
RTECS-Nr.
TW3666000

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 4 Einträge

ENALAPRIL MALEATE

Decreased Blood Pressure [PE]; Angiotensin-converting Enzyme Inhibitors [MoA]; Angiotensin Converting Enzyme Inhibitor [EPC]

ENALAPRIL MALEATE ORAL SOLUTION

Angiotensin Converting Enzyme Inhibitor [EPC]; Decreased Blood Pressure [PE]; Angiotensin-converting Enzyme Inhibitors [MoA]

MeSH Pharmacological Classification · 2 Einträge

A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Anwendungen · 2 Einträge

BeschreibungEnalapril maleate is the second angiotensin converting enzyme inhibitor to reach the marketplace. Like captopril, the first entry in this area, enalapril is useful in the treatment of hypertension and congestive heart failure. It has a longer effective half-life than captopril, allowing once or twice-daily dosing, and appears to have a somewhat lower incidence of side effects.

VerwendenEnalapril maleate salt is used as a long-acting ACE inhibitor and antihypertensive, used to study diabetic angiopathy in diabetic rats and inhibition of ACE in hog plasma (I50=1.2nM). ACE inhibitors disturb the enin-angiotensin- aldosterone system. Additional ACE inhibitors include: Enalapril, Enalaprilat dihydrate, Enalaprilat, and Enalapril-d5 Maleate Salt, among others.

Vor- und nachgelagerte Produkte

Zugehörige Reaktionen

15
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 51211
HRID 51211als Produkt
Reaktionsgleichung von HRID 51212
HRID 51212als Produkt
Reaktionsgleichung von HRID 51213
HRID 51213als Produkt
Reaktionsgleichung von HRID 51214
HRID 51214als Produkt
Reaktionsgleichung von HRID 481758
HRID 481758als Produkt
Reaktionsgleichung von HRID 1059101
HRID 1059101als Produkt
Reaktionsgleichung von HRID 1059102
HRID 1059102als Produkt
Reaktionsgleichung von HRID 1059103
HRID 1059103als Produkt
ZurückSeite 1 von 2

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EC Number
278-375-7
Wasserlöslichkeit
Soluble in water, methanol, and ethanol.
Merck
14 · 14,3567
BCS Class
1 · 1 (LogP), 3 (CLogP)
Major Application
pharmaceutical
InChIKey
OYFJQPXVCSSHAI-QFPUQLAESA-N
SMILES
C[C@@H](C(N1[C@H](C(O)=O)CCC1)=O)N[C@H](CC(OCC)=O)CCC2=CC=CC=C2.O=C(OO)/C=C\C(O)=O
CAS Datenbank
76095 · 76095-16-4(CAS DataBase Reference)
risk_code
36/37/38-62-63
Toxizität
LD50 oral in rat: 2973mg/kg
hazard_code
Xi,Xn
safety_code
22-24/25-36/37-26
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Repr. 2

Vorgelagerte Rohstoffe

Zeolithe1-L-Alanyl-L-prolinMaleinsäureEthyl-2-oxo-4-phenylbutyratAluminium-nickel

Nachgelagerte Produkte

EnalaprilEnalaprilat
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: The maleic acid salt of enalapril. It contains one molecule of maleic acid for each molecule of enalapril. Following oral administration, the ethyl ester group of enalapril is hydrolysed to afford the corresponding carboxylic acid, enalaprilat, an angioten in-converting enzyme (ACE) inhibitor. Enalapril is thus a prodrug for enalaprilat (which, unlike enalapril, is not absorbed by mouth), and its maleate is used in the treatment of hypertension and heart failure, for reduction of proteinuria and renal diseas in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients.